Claudia Polloni

561 total citations
16 papers, 189 citations indexed

About

Claudia Polloni is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Claudia Polloni has authored 16 papers receiving a total of 189 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 13 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Claudia Polloni's work include Multiple Myeloma Research and Treatments (14 papers), Protein Degradation and Inhibitors (10 papers) and Peptidase Inhibition and Analysis (7 papers). Claudia Polloni is often cited by papers focused on Multiple Myeloma Research and Treatments (14 papers), Protein Degradation and Inhibitors (10 papers) and Peptidase Inhibition and Analysis (7 papers). Claudia Polloni collaborates with scholars based in Italy and Brazil. Claudia Polloni's co-authors include Massimo Offidani, Laura Corvatta, Silvia Gentili, Massimo Catarini, Pietro Leoni, Francesco Alesiani, Marino Brunori, Giuseppe Visani, Mario Boccadoro and Piero Galieni and has published in prestigious journals such as Blood, British Journal of Haematology and European Journal Of Haematology.

In The Last Decade

Claudia Polloni

14 papers receiving 186 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudia Polloni Italy 8 167 136 106 22 6 16 189
J Píza Canada 2 232 1.4× 200 1.5× 146 1.4× 21 1.0× 5 0.8× 3 270
Billy Clowney United States 6 220 1.3× 173 1.3× 144 1.4× 27 1.2× 2 0.3× 7 233
Olga Samoilova United States 2 296 1.8× 250 1.8× 192 1.8× 30 1.4× 4 0.7× 2 313
Nicholas Pirooz United States 4 255 1.5× 222 1.6× 161 1.5× 22 1.0× 5 0.8× 7 276
Nina Shah United States 4 97 0.6× 66 0.5× 65 0.6× 10 0.5× 10 1.7× 5 124
Yousuf Gaffar United States 6 202 1.2× 188 1.4× 149 1.4× 23 1.0× 2 0.3× 9 218
Belén Hernández Spain 3 207 1.2× 131 1.0× 84 0.8× 20 0.9× 2 0.3× 6 227
Paz Ribas Spain 7 152 0.9× 87 0.6× 74 0.7× 11 0.5× 18 3.0× 15 180
Sarah Mangles United Kingdom 7 119 0.7× 61 0.4× 56 0.5× 28 1.3× 7 1.2× 15 190
Adrienne Briggs United States 5 191 1.1× 142 1.0× 118 1.1× 21 1.0× 1 0.2× 8 214

Countries citing papers authored by Claudia Polloni

Since Specialization
Citations

This map shows the geographic impact of Claudia Polloni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Polloni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Polloni more than expected).

Fields of papers citing papers by Claudia Polloni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Polloni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Polloni. The network helps show where Claudia Polloni may publish in the future.

Co-authorship network of co-authors of Claudia Polloni

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Polloni. A scholar is included among the top collaborators of Claudia Polloni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Polloni. Claudia Polloni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Polloni, Claudia, et al.. (2023). Seizures in pediatric emergency and autoimmune encephalitis, an essential and challenging differential diagnosis: a case report. Arquivos de Neuro-Psiquiatria. 81(S 01). S1–S96.
2.
Offidani, Massimo, Claudia Polloni, Federica Cavallo, et al.. (2012). Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myeloma. Leukemia & lymphoma. 53(9). 1722–1727. 41 indexed citations
3.
Offidani, Massimo, Laura Corvatta, Claudia Polloni, et al.. (2012). Assessment of Vulnerability Measures and Their Effect on Survival in a Real-Life Population of Multiple Myeloma Patients Registered at Marche Region Multiple Myeloma Registry. Clinical Lymphoma Myeloma & Leukemia. 12(6). 423–432. 36 indexed citations
4.
Offidani, Massimo, Laura Corvatta, Claudia Polloni, et al.. (2011). Infectious complications in patients with multiple myeloma treated with new drug combinations containing thalidomide. Leukemia & lymphoma. 52(5). 776–785. 17 indexed citations
5.
Offidani, Massimo, Laura Corvatta, Claudia Polloni, et al.. (2011). Thalidomide, dexamethasone, Doxil and Velcade (ThaDD-V) followed by consolidation/maintenance therapy in patients with relapsed–refractory multiple myeloma. Annals of Hematology. 90(12). 1449–1456. 14 indexed citations
6.
Offidani, Massimo, Claudia Polloni, Laura Corvatta, et al.. (2011). Assessment of Frailty Measures and Their Effect on Survival in a Population of Patients Registered At Marche Region Multiple Myeloma (MM) Registry. Blood. 118(21). 2873–2873. 1 indexed citations
7.
Offidani, Massimo, Pietro Leoni, Laura Corvatta, et al.. (2010). ThaDD plus high dose therapy and autologous stem cell transplantation does not appear superior to ThaDD plus maintenance in elderly patients with de novo multiple myeloma. European Journal Of Haematology. 84(6). 474–483. 12 indexed citations
8.
Offidani, Massimo, Pietro Leoni, Laura Corvatta, et al.. (2010). Outcome and Toxicity in the Modern Era of New Drugs for Multiple Myeloma: A Reappraisal for Comparison With Future Investigational Trials. Clinical Lymphoma Myeloma & Leukemia. 10(5). 353–360. 2 indexed citations
9.
Offidani, Massimo, Pietro Leoni, Sara Bringhen, et al.. (2010). Melphalan, prednisone, and thalidomide versus thalidomide, dexamethasone, and pegylated liposomal doxorubicin regimen in very elderly patients with multiple myeloma: a case-match study. Leukemia & lymphoma. 51(8). 1444–14449. 4 indexed citations
10.
Offidani, Massimo, Federica Cavallo, Claudia Polloni, et al.. (2010). Melphalan, Thalidomide and Prednisone (MPT) Combined with Oral Panobinostat In Patients with Relapsed/Refractory MM: a Phase I-II Study. Blood. 116(21). 3019–3019. 5 indexed citations
11.
Offidani, Massimo, Laura Corvatta, Claudia Polloni, et al.. (2008). Thalidomide‐dexamethasone versus Interferon‐alpha‐dexamethasone as maintenance treatment after ThaDD induction for multiple myeloma: a prospective, multicentre, randomised study. British Journal of Haematology. 144(5). 653–659. 23 indexed citations
12.
Offidani, Massimo, Laura Corvatta, Claudia Polloni, et al.. (2008). Serum C-Reactive Protein at Diagnosis and Response to Therapy Is the Most Powerful Factor Predicting Outcome of Multiple Myeloma Treated with Thalidomide/Anthracycline—Based Therapy. Clinical Lymphoma & Myeloma. 8(5). 294–299. 9 indexed citations
13.
Offidani, Massimo, Sara Galimberti, Laura Corvatta, et al.. (2007). Thalidomide–dexamethasone plus pegylated liposomal doxorubicin vs. thalidomide–dexamethasone: a case‐matched study in advanced multiple myeloma. European Journal Of Haematology. 78(4). 297–302. 22 indexed citations
14.
Offidani, Massimo, Claudia Polloni, Laura Corvatta, et al.. (2007). ThaDD-V Treatment for Patients with Relapsed/Refractory Multiple Myeloma: A Feasibility/Activity Study.. Blood. 110(11). 2729–2729. 1 indexed citations
15.
16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Píza Breakdown of academic impact, for papers by Billy Clowney Breakdown of academic impact, for papers by Olga Samoilova Breakdown of academic impact, for papers by Nicholas Pirooz Breakdown of academic impact, for papers by Nina Shah Breakdown of academic impact, for papers by Yousuf Gaffar Breakdown of academic impact, for papers by Belén Hernández Breakdown of academic impact, for papers by Paz Ribas Breakdown of academic impact, for papers by Sarah Mangles Breakdown of academic impact, for papers by Adrienne Briggs
Rankless by CCL
2026